Hepatocellular Carcinoma With Right Atrium Metastases

Area of Science:

• Hepatology
• Oncology
• Gastroenterology

Background:

• Hepatocellular carcinoma (HCC) is frequently diagnosed in patients with cirrhosis, irrespective of its cause.
• While uncommon in individuals without known cirrhosis, HCC can metastasize to the lungs, lymph nodes, and bone, with cardiac involvement being rare.
• Alcohol consumption and viral hepatitis B and C are primary causes of cirrhosis and HCC, but non-alcoholic fatty liver disease (NAFLD) is an emerging risk factor due to increasing metabolic syndrome prevalence.

Observation:

• This study describes an unusual initial presentation of hepatocellular carcinoma.
• The case highlights the potential for HCC to occur in patients without a prior diagnosis of cirrhosis.
• Cardiac metastases from HCC, though rare, are noted in the context of its common metastatic sites.

Findings:

• Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a significant risk factor for hepatic steatosis, advanced fibrosis, cirrhosis, and subsequent HCC development.
• Despite NAFLD being a known risk factor, current medical guidelines lack specific recommendations for cancer surveillance in affected patients.
• The paper aims to increase awareness regarding the rising incidence of HCC linked to NAFLD.

Implications:

• Early screening and diagnosis of HCC are crucial for improving treatment efficacy and patient prognosis.
• There is a need to develop and implement cancer surveillance strategies for patients with NAFLD.
• Recognizing rare presentations of HCC is important for timely diagnosis and management, especially in the context of evolving risk factors like NAFLD.